chr2-201267384-C-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001372051.1(CASP8):c.305+593C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.109 in 152,058 control chromosomes in the GnomAD database, including 1,452 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.11 ( 1452 hom., cov: 32)
Consequence
CASP8
NM_001372051.1 intron
NM_001372051.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.705
Genes affected
CASP8 (HGNC:1509): (caspase 8) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.269 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CASP8 | NM_001372051.1 | c.305+593C>A | intron_variant | Intron 2 of 8 | ENST00000673742.1 | NP_001358980.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.109 AC: 16550AN: 151940Hom.: 1447 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
16550
AN:
151940
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.109 AC: 16584AN: 152058Hom.: 1452 Cov.: 32 AF XY: 0.112 AC XY: 8334AN XY: 74312 show subpopulations
GnomAD4 genome
AF:
AC:
16584
AN:
152058
Hom.:
Cov.:
32
AF XY:
AC XY:
8334
AN XY:
74312
Gnomad4 AFR
AF:
AC:
0.217665
AN:
0.217665
Gnomad4 AMR
AF:
AC:
0.0521637
AN:
0.0521637
Gnomad4 ASJ
AF:
AC:
0.0861175
AN:
0.0861175
Gnomad4 EAS
AF:
AC:
0.20954
AN:
0.20954
Gnomad4 SAS
AF:
AC:
0.281652
AN:
0.281652
Gnomad4 FIN
AF:
AC:
0.0395459
AN:
0.0395459
Gnomad4 NFE
AF:
AC:
0.0470727
AN:
0.0470727
Gnomad4 OTH
AF:
AC:
0.101326
AN:
0.101326
Heterozygous variant carriers
0
677
1354
2031
2708
3385
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
186
372
558
744
930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
817
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at